Get App Open
In App
Lending
Lending
Open App
you are here:

Windlas Biotech Ltd.

BSE: 543329 | NSE: WINDLAS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE0H5O01029 | SECTOR: Biotechnology & Medical Research

BSE Live

Oct 30, 16:01
946.25 -8.90 (-0.93%)
Volume
AVERAGE VOLUME
5-Day
4,003
10-Day
4,800
30-Day
8,637
817
  • Prev. Close

    955.15

  • Open Price

    956.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 30, 15:55
946.95 -9.35 (-0.98%)
Volume
AVERAGE VOLUME
5-Day
35,427
10-Day
56,675
30-Day
97,252
17,520
  • Prev. Close

    956.30

  • Open Price

    956.30

  • Bid Price (Qty.)

    946.95 (1)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Balance Sheet of Windlas Biotech (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22  
  12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 10.48 10.40 10.46 10.90  
Total Share Capital 10.48 10.40 10.46 10.90  
Reserves and Surplus 495.29 439.54 391.81 383.88  
Total Reserves and Surplus 495.29 439.54 391.81 383.88  
Total Shareholders Funds 505.77 449.94 402.27 394.78  
Minority Interest 0.00 0.00 0.00 0.00  
NON-CURRENT LIABILITIES  
Long Term Borrowings 0.00 0.00 0.11 0.44  
Deferred Tax Liabilities [Net] 0.00 0.00 0.00 0.00  
Other Long Term Liabilities 2.35 2.20 3.34 0.24  
Long Term Provisions 2.88 2.32 2.02 1.57  
Total Non-Current Liabilities 5.24 4.52 5.46 2.25  
CURRENT LIABILITIES  
Short Term Borrowings 27.12 0.11 0.34 5.68  
Trade Payables 167.24 131.51 87.74 63.23  
Other Current Liabilities 53.53 39.41 32.72 24.75  
Short Term Provisions 1.56 0.73 0.45 0.33  
Total Current Liabilities 249.44 171.75 121.24 93.99  
Total Capital And Liabilities 760.45 626.21 528.98 491.01  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 218.73 174.58 108.90 90.73  
Intangible Assets 4.66 4.47 0.51 0.45  
Capital Work-In-Progress 3.20 5.71 13.80 7.58  
Fixed Assets 228.71 184.76 124.19 99.20  
Non-Current Investments 0.00 0.00 0.00 0.00  
Deferred Tax Assets [Net] 0.28 0.57 2.03 6.13  
Long Term Loans And Advances 0.00 0.00 0.00 0.00  
Other Non-Current Assets 6.33 9.59 49.23 8.13  
Total Non-Current Assets 235.32 194.92 175.44 113.46  
CURRENT ASSETS  
Current Investments 223.37 173.44 106.51 64.82  
Inventories 81.38 62.19 74.74 58.71  
Trade Receivables 166.86 136.28 116.86 110.77  
Cash And Cash Equivalents 15.93 30.95 25.45 113.82  
Short Term Loans And Advances 0.00 0.00 0.00 0.00  
OtherCurrentAssets 37.59 28.44 29.97 29.43  
Total Current Assets 525.13 431.29 353.54 377.56  
Total Assets 760.45 626.21 528.98 491.01  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 2.08 15.29 14.11 3.25  
BONUS DETAILS  
Bonus Equity Share Capital 2.69 2.69 2.69 2.69  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value 0.00 0.00 0.00 0.00  
Non-Current Investments Unquoted Book Value 0.00 0.00 0.00 0.00  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value 223.37 173.44 106.51 0.00  
Current Investments Unquoted Book Value 0.00 0.00 0.00 64.82  
Source : Dion Global Solutions Limited

Results of Biotechnology & Medical Research Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347